Navigation Links
ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
Date:3/4/2013

SAN CLEMENTE, Calif., March 4, 2013 /PRNewswire/ -- ROX Medical announced enrollment of the first two Irish patients in the CONTROL-HTN randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension. Both patients were evaluated by hypertension specialists, Professor Alice Stanton , M.D. of Beaumont Hospital and Eamon Dolan , M.D. of Connolly Hospital in Dublin. One of the two patients was randomized to receive the ROX FLOW procedure, which was performed by Joseph Galvin , M.D. at The Mater Private Hospital, Dublin, Ireland. The minimally invasive procedure was performed in the cardiac catheter lab in less than one hour. The ROX procedure is a reversible therapy option for the management of resistant hypertension and may offer an alternative and/or concomitant therapy option to another increasingly popular hypertension procedure, renal denervation.

(Logo: http://photos.prnewswire.com/prnh/20130304/LA70984LOGO)

ROX Medical's FLOW procedure is a minimally invasive, catheter procedure whereby a small nitinol coupler is inserted between the artery and vein in the upper leg. The procedure reduces peripheral vascular resistance, thereby holding the promise of a meaningful long-term reduction in hypertension.  Uniquely, the FLOW procedure only involves the vascular structure, has an immediate effect; and is fully reversible.

"We congratulate the physicians at Beaumont, Connolly and Mater Private hospitals for their first successful enrollments in the CONTROL-HTN study", said ROX CEO Rodney Brenneman . "The ROX procedure is unique in providing a complimentary and/or alternative therapy option to the other major device approach, renal denervation", Brenneman said, "Device approaches are becoming accepted as important additional therapies physicians may employ for the thousands of uncontrolled hypertensive patients throughout the world".

The ROX FLOW procedure for hypertension is not approved for use in the U.S.


'/>"/>
SOURCE ROX Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
2. Richard Wolf Medical Instruments Launches Narrow-Channel Reprocessing Training
3. Medical Alarm Concepts Provides Investor Update - Signs Deal with Health Care Insurance Provider for Medical Alarms
4. Medical Device Contract Manufacturing: World Market Outlook 2013-2023
5. SurgiCount Medical Launches New Surgical Sponge Product
6. Nonin Medical als exklusiver Anbieter für zerebrales/somatisches Oximetriesystems an führenden Kinderkliniken in Polen ausgewählt
7. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
8. Accelovance Expands Oncology Leadership with the Addition of Ralph Boccia, MD as Oncology Medical Director
9. Nonin Medical Selected as Exclusive Provider of Cerebral/Somatic Oximetry Systems to Leading Pediatric Hospitals in Poland
10. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
11. GPMG Product Helps Medical Device Specification Developers be FDA and ISO 13485 Compliant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/11/2017)... 11, 2017 DarioHealth Corp. (NASDAQ: DRIO), a ... big data solutions, today announced that it will release ... and host a conference call at 9:00am ET. The ... financial results and its strategy and outlook for the ... Erez Raphael , Chief Executive Officer, and ...
(Date:8/7/2017)... 2017 Zimmer Biomet Holdings, Inc. (NYSE and SIX: ... its Board of Directors has approved the payment of a ... 2017. The cash dividend ... October 27, 2017 to stockholders of record as of the ... dividends are subject to approval of the Board of Directors ...
(Date:8/4/2017)... , Aug. 3, 2017  Agragen, LLC, ... company active in the biopharmaceutical, nutraceutical, and aquacultural ... development of its lead drug candidates, AGR131.  This ... proinflammatory cytokine from the blood of patients suffering ... and inflammatory bowel disease. ...
Breaking Medicine Technology:
(Date:8/16/2017)... ... , ... Maury Regional Health has announced a large-scale adoption of AccuVein vein ... Maury Regional Medical Center is making vein visualization part of their standard of care. ... more importantly, helps our staff members locate a vein that will provide good access ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD ... ultimately, a cure. , The grants are awarded through a competitive application process ... a wide array of backgrounds and expertise in all areas relevant to PD research. ...
(Date:8/16/2017)... Sacramento, CA (PRWEB) , ... August 16, 2017 ... ... ($10.99, paperback, 9781498499613; $5.99, eBook, 9781498499620    ) shares that during the time of a ... as reminding Strawn of God's love, and all the many ways God shows ...
(Date:8/16/2017)... ... August 16, 2017 , ... Women’s Excellence in ... pain. In addition to oncology services, the new center will specialize in ... heavy bleeding during menstruation), uterine fibroids, and uterine and pelvic adhesions (scar tissue). ...
(Date:8/16/2017)... ... ... pain afflicting 8 of 10 Americans at some point in their lives, some of us ... equally vexing condition stems from a variety of causes that can be effectively targeted by ... president of Atlantic Spine Center. , Nestled between your neck and lower back, the ...
Breaking Medicine News(10 mins):